Therapeutic potential of murine mesenchymal stem cells (MSC) from different origins in the treatment of muscular dystrophy (2010)
- Authors:
- Autor USP: VAINZOF, MARIZ - IB
- Unidade: IB
- DOI: 10.1016/j.nmd.2010.07.165
- Subjects: MODELOS ANIMAIS DE DOENÇAS; DISTROFIA MUSCULAR; CÉLULAS-TRONCO
- Language: Inglês
- Imprenta:
- Publisher: Elsevier Science
- Publisher place: Oxford
- Date published: 2010
- Source:
- Título do periódico: Neuromuscular Disorders
- ISSN: 0960-8966
- Volume/Número/Paginação/Ano: v. 20, n. 9-10, p. 648, res. P3.23, oct. 2010
- Conference titles: International Congress of the World Muscle Society
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ONOFRE-OLIVEIRA, P C G et al. Therapeutic potential of murine mesenchymal stem cells (MSC) from different origins in the treatment of muscular dystrophy. Neuromuscular Disorders. Oxford: Elsevier Science. Disponível em: https://doi.org/10.1016/j.nmd.2010.07.165. Acesso em: 23 abr. 2024. , 2010 -
APA
Onofre-Oliveira, P. C. G., Martins-Machado, P., Ayub-Guerrieri, D., Gotlieb, D., Fernandes, A., Yamamoto, L. U., & Vainzof, M. (2010). Therapeutic potential of murine mesenchymal stem cells (MSC) from different origins in the treatment of muscular dystrophy. Neuromuscular Disorders. Oxford: Elsevier Science. doi:10.1016/j.nmd.2010.07.165 -
NLM
Onofre-Oliveira PCG, Martins-Machado P, Ayub-Guerrieri D, Gotlieb D, Fernandes A, Yamamoto LU, Vainzof M. Therapeutic potential of murine mesenchymal stem cells (MSC) from different origins in the treatment of muscular dystrophy [Internet]. Neuromuscular Disorders. 2010 ; 20( 9-10): 648.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.nmd.2010.07.165 -
Vancouver
Onofre-Oliveira PCG, Martins-Machado P, Ayub-Guerrieri D, Gotlieb D, Fernandes A, Yamamoto LU, Vainzof M. Therapeutic potential of murine mesenchymal stem cells (MSC) from different origins in the treatment of muscular dystrophy [Internet]. Neuromuscular Disorders. 2010 ; 20( 9-10): 648.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.nmd.2010.07.165 - Immune-mediated rippling muscle disease in a patient with treated hypothyroidism. [Carta]
- Reduction of acethylcolinesterase activity in the brain of mdx mice
- Motor Chip: A comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders
- Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies
- Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date
- Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice
- Mitochondrial alterations in dynamin 2-related centronuclear myopathy
- Osteopontin expression during chronic and acute muscle injury
- Correction to: effects of low-intensity training on the brain and muscle in the congenital muscular dystrophy 1D model
- Myostatin expression in different mice models for neuromuscular disorders
Informações sobre o DOI: 10.1016/j.nmd.2010.07.165 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
